AquaBounty: FDA could approve biotech salmon this year

04/24/2013 | Hartford Courant (Conn.), The

AquaBounty Technologies expects its biotech salmon, which grows twice as fast as traditional salmon, to be approved by the FDA before the year ends. "There have been no new legal issues, no new regulatory issues, no new environmental issues raised," CEO Ronald Stotish said at the BIO International Convention. The public comment period ends on Friday, and the FDA's decision could come 150 to 180 days later, Stotish said.

View Full Article in:

Hartford Courant (Conn.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ